Biomea Fusion, Inc is a biotechnology business based in the US. Biomea Fusion shares (BMEA) are listed on the NASDAQ and all prices are listed in US Dollars. Biomea Fusion employs 20 staff and has a market cap (total outstanding shares value) of 0.00.
How to buy shares in Biomea Fusion
- Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – BMEA – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
Biomea Fusion stock price (NASDAQ: BMEA)Use our graph to track the performance of BMEA stocks over time.
Biomea Fusion shares at a glance
|52-week range||$12.22 - $22.22|
|50-day moving average||$16.36|
|200-day moving average||$16.83|
|Wall St. target price||$26.50|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||N/A|
Buy Biomea Fusion shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Biomea Fusion stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Biomea Fusion financials
|Gross profit TTM||$0|
|Return on assets TTM||-10.6%|
|Return on equity TTM||-17.49%|
|Market capitalisation||$380.3 million|
TTM: trailing 12 months
Shorting Biomea Fusion shares
There are currently 667,850 Biomea Fusion shares held short by investors – that's known as Biomea Fusion's "short interest". This figure is 24.6% down from 885,759 last month.
There are a few different ways that this level of interest in shorting Biomea Fusion shares can be evaluated.
Biomea Fusion's "short interest ratio" (SIR)
Biomea Fusion's "short interest ratio" (SIR) is the quantity of Biomea Fusion shares currently shorted divided by the average quantity of Biomea Fusion shares traded daily (recently around 167380.95238095). Biomea Fusion's SIR currently stands at 3.99. In other words for every 100,000 Biomea Fusion shares traded daily on the market, roughly 3990 shares are currently held short.
To gain some more context, you can compare Biomea Fusion's short interest ratio against those of similar companies.
However Biomea Fusion's short interest can also be evaluated against the total number of Biomea Fusion shares, or, against the total number of tradable Biomea Fusion shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Biomea Fusion's short interest could be expressed as 0.02% of the outstanding shares (for every 100,000 Biomea Fusion shares in existence, roughly 20 shares are currently held short) or 0.0472% of the tradable shares (for every 100,000 tradable Biomea Fusion shares, roughly 47 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Biomea Fusion.
Find out more about how you can short Biomea Fusion stock.
Biomea Fusion share dividends
We're not expecting Biomea Fusion to pay a dividend over the next 12 months.
Biomea Fusion overview
Biomea Fusion, Inc. , a biopharmaceutical company, focuses on the discovery, development, and commercialization of irreversible small molecules to treat patients with genetically defined cancers. Its lead product candidate is BMF-219, an orally bioavailable, potent, and selective irreversible inhibitor of MENIN, a transcriptional regulator in oncogenic signaling in multiple cancers. The company was founded in 2017 and is based in Redwood City, California. .
Stocks similar to Biomea Fusion
Biomea Fusion in the news
The Daily Biotech Pulse: Pfizer, Bristol-Myers Squibb Earnings, Amgen Goes Shopping, GlaxoSmithKline-Vir's COVID-19 Antibody Treatment Supply Deal
The Daily Biotech Pulse: ObsEva Surges On Out-Licensing Deal, EyeGate Appoints New CEO, 2 Positive Catalysts For Merck, Candel Therapeutics Debuts
The Daily Biotech Pulse: Acorda Spikes On Distribution Deal, Alzamend Soars On Data, Pfizer-BioNTech To Supply More Vaccine Doses, 3 IPOs
Frequently asked questionsWhat percentage of Biomea Fusion is owned by insiders or institutions?
Currently 32.864% of Biomea Fusion shares are held by insiders and 22.263% by institutions. How many people work for Biomea Fusion?
Latest data suggests 20 work at Biomea Fusion. When does the fiscal year end for Biomea Fusion?
Biomea Fusion's fiscal year ends in December. Where is Biomea Fusion based?
Biomea Fusion's address is: Chamberlain Building, Redwood City, CA, United States, 94063
More guides on Finder
How to buy Argus Capital Corp (ARGU) stock when it goes public
Everything we know about the Argus Capital Corp IPO, plus information on how to buy in.
How to buy RenovoRx (RNXT) stock when it goes public
Everything we know about the RenovoRx IPO, plus information on how to buy in.
How to buy Draganfly (DPRO) stock when it goes public
Everything we know about the Draganfly IPO, plus information on how to buy in.
How to buy Society Pass Incorporated (SOPA) stock when it goes public
Everything we know about the Society Pass Incorporated IPO, plus information on how to buy in.
How to buy Guardforce AI Co (GFAI) stock when it goes public
Everything we know about the Guardforce AI Co IPO, plus information on how to buy in.
How to buy IsoPlexis Corporation (ISO) stock when it goes public
Everything we know about the IsoPlexis Corporation IPO, plus information on how to buy in.
How to buy Marpai (MRAI) stock when it goes public
Everything we know about the Marpai IPO, plus information on how to buy in.
How to buy DoubleDown Interactive (DDI) stock when it goes public
Everything we know about the DoubleDown Interactive IPO, plus information on how to buy in.
How to buy Omniq Corp (OMQS) stock when it goes public
Everything we know about the Omniq Corp IPO, plus information on how to buy in.
How to buy Mechanical Technology (MKTYP) stock when it goes public
Everything we know about the Mechanical Technology IPO, plus information on how to buy in.
Ask an Expert